YuvasaiKPSinghSPaiPJErlaSRPannuAK. Acute hepatic porphyria presenting as Guillain-Barré syndrome: importance of early recognition and screening. Neurohospitalist. 2025;19418744251331651. doi:10.1177/19418744251331651
2.
FinstererJ. Triggers of Guillain-Barré Syndrome: Campylobacter jejuni predominates. Int J Mol Sci. 2022;23(22):14222. doi:10.3390/ijms232214222
3.
AlthubaitiFGuiomardCRivierFMeyerPLeboucqN. Prognostic value of contrast-enhanced MRI in Guillain-Barré syndrome in children. Arch Pediatr. 2022;29(3):230-235. doi:10.1016/j.arcped.2022.01.004
4.
GhazanfarHQaziRGhazanfarAIftekharS. Significance of Brighton criteria in the early diagnosis and management of Guillain-Barré syndrome. Cureus. 2020;12(5):e8318. doi:10.7759/cureus.8318
5.
KothadiaJPLaFreniereKShahJM. Acute hepatic porphyria. In: StatPearls. Treasure Island, FL. [Updated 2023 May 1]. StatPearls Publishing; 2025. Available from. https://www.ncbi.nlm.nih.gov/books/NBK537178/
6.
YuanJPengBYouHZhangW. Clinical and neuroimaging features of central nervous system impairments in acute intermittent porphyria. Zhonghua Yixue Zazhi. 2011;91(39):2776-2778.
